Orthopaedics

Study into Cancer risk in the first seven years after Metal-on-Metal Hip Replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics.

Biomet has an exclusive, binding offer of $280M on the table for J&J’s DePuy Trauma division. The deal is thought to represent J&J’s concession, extracted from the leviathan by an EU commission, in order to ratify its $21Bn takeover of Synthes.

UK MHRA singles out specific combinations of hip/stem for attention, this alert proving the value of the data in England and Wales Joint Registry.

Consolidation of contract manufacturing of medical devices, as Sandvik Medical Solutions finds a new home following its acquisition by Orchid Orthopaedic Solutions.

It looks like it’s invitation only for the FDA panel review meeting to be held in June, at which experts will discuss all aspects of the Metal-on-Metal hip disaster.

Let’s face facts. Medical device regulation is by definition imperfect, however much we fiddle with it. The world’s toughest regulator is apparently a pussycat allowing devices onto the market without such as a by-your-leave. If you believe the so-well-informed media.

Biomet is paying out a lot of money to settle it’s bribery allegations case with US SEC and Justice Department.

Integra sees fruits of its acquisition of Ascension Orthopaedics in the form of first European implants of the company’s shoulder resurfacing arthroplasty.

Millennium Research Group predict modest growth in large joint market as price pressure waters down procedure growth.

Sanofi’s acquisition trail continues with announcement that it is to buy US company Pluromed, developer of LeGoo® polymer for temporary endovascular occlusion.

Dynatron Quad7 is a cool name for what Dynatronics claims is a cool product. It’s new device avoids the need for ice in delivery of cold therapy for sports medicine and physical therapy.

Wright has launched its Claw® II Polyaxial Compression plating system which it claims offers foot and ankle surgeons the possibility of matching the implant to the patient’s circumstances.

Snappy dressers these new powertools from Stryker, offering a range of “enhancements” including quieter operation, better battery life and heightened torque.

Did you hear the one about the company that thought it had a winner on its hands by developing its own version of an increasingly popular type of hip replacement?

Checkpoint’s newly CE marked device helps surgeons avoid nerve damage.

MHRA fights back against media claims that it needs to “recover its grip” over medical device regulation in light of the metal-on-metal hip situation.